A61K45/00- Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00.A61K31/325- Carbamic acids Thiocarbamic acids Anhydrides or salts thereof.nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine A61K31/03- Halogenated hydrocarbons carbocyclic aromatic.A61K31/025- Halogenated hydrocarbons carbocyclic.A61K31/00- Medicinal preparations containing organic active ingredients.A61K- PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES.A61- MEDICAL OR VETERINARY SCIENCE HYGIENE.C07C271/02- Carbamic acids Salts of carbamic acids.compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups C07C271/00- Derivatives of carbamic acids, i.e.UCTRAOBQFUDCSR-SECBINFHSA-N Chemical compound UCTRAOBQFUDCSR-SECBINFHSA-N 0.000 description 4.UCTRAOBQFUDCSR-UHFFFAOYSA-N NC(=O)OCC(N)CC1=CC=CC=C1 Chemical compound NC(=O)OCC(N)CC1=CC=CC=C1 UCTRAOBQFUDCSR-UHFFFAOYSA-N 0.000 description 4.Assignors: JAZZ PHARMACEUTICALS IRELAND LIMITED Status Active legal-status Critical Current Adjusted expiration legal-status Critical Links ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Priority to US17/383,707 priority patent/US20220017457A1/en Assigned to AXSOME MALTA LTD. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assigned to Jazz Pharmaceuticals, Inc., JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED, JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED, CELATOR PHARMACEUTICALS, INC., CAVION, INC., JAZZ PHARMACEUTICALS IRELAND LIMITED reassignment Jazz Pharmaceuticals, Inc. BANK NATIONAL ASSOCIATION SECURITY AGREEMENT Assignors: CAVION, INC., CELATOR PHARMACEUTICALS, INC., JAZZ PHARMACEUTICALS IRELAND LIMITED, Jazz Pharmaceuticals, Inc. BANK NATIONAL ASSOCIATION reassignment U.S. Assignors: JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED Assigned to U.S. Priority to US15/149,478 priority patent/US9585863B2/en Application granted granted Critical Publication of US9359290B2 publication Critical patent/US9359290B2/en Priority to US15/419,133 priority patent/US10259780B2/en Priority to US16/359,446 priority patent/US11072579B2/en Assigned to JAZZ PHARMACEUTICALS IRELAND LIMITED reassignment JAZZ PHARMACEUTICALS IRELAND LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assigned to BANK OF AMERICA, N.A., AS COLLATERAL AGENT reassignment BANK OF AMERICA, N.A., AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED, JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED, JAZZ PHARMACEUTICALS IRELAND LIMITED, Jazz Pharmaceuticals, Inc. Assignors: BUTTS, STEPHEN E., BREAM, GARY, KHAYRALLAH, MOISE A. reassignment JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US201361778998P external-priority Priority to US14/205,423 priority Critical patent/US9359290B2/en Application filed by SK Biopharmaceuticals Co Ltd, AERIAL BIOPHARMA LLC filed Critical SK Biopharmaceuticals Co Ltd Publication of US20140275244A1 publication Critical patent/US20140275244A1/en Assigned to JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED, SK BIOPHARMACEUTICALS CO., LTD. Original Assignee SK Biopharmaceuticals Co Ltd AERIAL BIOPHARMA LLC Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Butts Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number US14/205,423 Other versions US9359290B2
0 kommentar(er)
